Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.23.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Class A Preferred Shares
Class A Preferred Shares
Common Shares
Additional Paid-in Capital
Accumulated Deficit
Non-controlling Interest
Total
Balance at Dec. 31, 2020     $ 75,627,000 $ (73,268,000)   $ 2,359,000
Balance (in shares) at Dec. 31, 2020 250,000 1,116,505        
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY            
Share based compensation     442,000     442,000
Share based compensation (in shares) 0 12,803        
Issuance of common shares, net of costs     4,381,000     4,381,000
Issuance of common shares, net of costs (in shares) 0 276,592        
Cashless exercise of warrants (in shares) 0 59        
Net loss attributable to non-controlling interests           0
Net loss $ 0     (3,731,000)   (3,731,000)
Balance at Dec. 31, 2021     80,450,000 (76,999,000)   3,451,000
Balance (in shares) at Dec. 31, 2021 250,000 1,405,959        
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY            
Share based compensation $ 0   649,000     649,000
Share based compensation (in shares)   75,505        
Common shares issuable - Founders Agreement 0   526,000     526,000
Issuance of common shares and pre-funded warrants at private placement, net of issuance costs 0   3,205,000     3,205,000
Issuance of common shares and pre-funded warrants at private placement, net of issuance costs (in shares)   3,636,365        
US Repurchase of common stock held by InvaGen 0   (1,104,000)     (1,104,000)
Repurchase of common stock held by InvaGen (in shares)   (388,888)        
Fortress contribution of Baergic Inc 0   (99,000)     (99,000)
Issuance of subsidiaries' common shares for license expenses 0   4,000     4,000
Exercise of warrants 0   237,000     237,000
Exercise of warrants (in shares)   44,900        
Non-controlling interest in subsidiaries 0   588,000   $ (588,000)  
Net loss attributable to non-controlling interests 0       (51,000) (51,000)
Net loss attributable to common stockholders $ 0     (3,552,000)   (3,552,000)
Net loss           (3,552,000)
Balance at Dec. 31, 2022     $ 84,456,000 $ (80,551,000) $ (639,000) $ 3,266,000
Balance (in shares) at Dec. 31, 2022 250,000 4,773,841